Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

YM-47813 revealed at 211th ACS

April 19, 1996

Taisho reports 5-HT4 agonists for GI disorders

April 19, 1996

FDA approves Prilosec + Biaxin combination for H. pylori

April 19, 1996

Byk Gulden researches anti-Helicobacter agents

April 19, 1996

Vaqta gets the green light from FDA

April 12, 1996

Nisin in testing for Helicobacter infections

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

OraVax granted patent on H. pylori vaccine technology

April 12, 1996

Provir to enter phase II soon

April 5, 1996

Lexipafant for pancreatitis

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 9, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave
BioWorld MedTech
Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...